Population-level benefits of correctional medications for opioid use disorder

Rosemarie Martin, Ryan Carpenter, Ariel Hoadley, Amelia Bailey, Augustine Kang, Josiah Rich, Damaris Rohsenow, Linda Hurley, Jennifer Clarke

Open source

DOI
10.1016/j.josat.2026.210111
Published
2026-12
Container
Journal of Substance Use and Addiction Treatment
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.josat.2026.210111,
  title = {Population-level benefits of correctional medications for opioid use disorder},
  author = {Rosemarie Martin and Ryan Carpenter and Ariel Hoadley and Amelia Bailey and Augustine Kang and Josiah Rich and Damaris Rohsenow and Linda Hurley and Jennifer Clarke},
  year = {2026},
  journal = {Journal of Substance Use and Addiction Treatment},
  doi = {10.1016/j.josat.2026.210111},
  url = {https://doi.org/10.1016/j.josat.2026.210111}
}

RIS

TY  - JOUR
TI  - Population-level benefits of correctional medications for opioid use disorder
AU  - Rosemarie Martin
AU  - Ryan Carpenter
AU  - Ariel Hoadley
AU  - Amelia Bailey
AU  - Augustine Kang
AU  - Josiah Rich
AU  - Damaris Rohsenow
AU  - Linda Hurley
AU  - Jennifer Clarke
PY  - 2026
JO  - Journal of Substance Use and Addiction Treatment
DO  - 10.1016/j.josat.2026.210111
UR  - https://doi.org/10.1016/j.josat.2026.210111
ER  - 

APA

Martin, R., Carpenter, R., Hoadley, A., Bailey, A., Kang, A., Rich, J., Rohsenow, D., Hurley, L., & Clarke, J. (2026). Population-level benefits of correctional medications for opioid use disorder. Journal of Substance Use and Addiction Treatment. https://doi.org/10.1016/j.josat.2026.210111

Source records